# Hemideina

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hemideina

- Industry: Medical Devices & Equipment
- Headquarters: Melbourne, Australia
- Website: www.hemideina.com
- Total disclosed funding: $10M
- Latest round: Series A (Feb 22, 2021)
- Investors on record: 15

## About

Hemideina develops innovative medical devices, specifically the Hera Cochlear Implant, which addresses severe sensorineural hearing loss through advanced technology that improves auditory experiences for users.Hemideina, founded in 2017 in Melbourne, Australia, specializes in creating solutions for individuals with hearing loss. The company has received funding from multiple investors including Applecross Secretarial Services Pty. Ltd. and First Samuel Limited, raising USD 10.00 mn in its SERIES A round, which represents the total amount raised so far. The company was founded by Kate Lomas, and currently led by CEO Liz Gaicd.Hemideina's core product offering is the Hera Cochlear Implant, designed to address severe sensorineural hearing loss in individuals who derive limited or no benefit from traditional hearing aids. The Hera Implant consists of a small external sound processor discreetly positioned in the ear, transmitting sound through the ear canal to an implant that electrically stimulates the cochlea. This technology uses miniature wireless powering to optimize the ear's anatomy, eliminating bulky headpieces found in conventional implants. The primary clientele includes individuals with moderate-to-profound hearing loss, particularly in developed markets where demand for advanced hearing solutions is high.Hemideina's revenue structure is primarily transactional, through direct sales of the Hera Cochlear Implant as well as partnerships with healthcare providers. The company collaborates with hospitals and audiology clinics to enhance product accessibility for patients in need. Revenue is generated by the sale of the Hera Cochlear Implant, with pricing plans reflecting the unique features of the technology, supporting the goal of providing innovative solutions for individuals with significant hearing loss.Hemideina plans to leverage recent funding to accelerate the development of new products and enhance its market presence. The company is focused on expanding into new geographic regions, particularly targeting emerging markets in Asia and Europe by 2025. Recent funding from Common Sense Ventures will support these initiatives, enhancing their capacity to bring advanced hearing solutions to a broader audience.

## Funding rounds

- Series A, Feb 22, 2021, $10M — InterValley Ventures, Escala Partners, Fifty-Second Celebration, Geoni Capital, First Samuel Limited, Applecross Secretarial Services Pty. Ltd., Binco Securities Pty. Limited, Gwb Superannuation Pty Ltd, Mal-Fam Nominees Pty. Limited, Moore Family Nominee Pty Limited, Our Barnyard Pty Ltd, Radiata Super Pty Ltd, Rothwell Holdings Pte. Ltd., Shiawaseyo Pty Ltd, Warana Grange Pty. Ltd.

## Investors

- InterValley Ventures (https://capitalatlas.ai/funds/intervalley-ventures) — Series A
- Escala Partners — Series A
- Fifty-Second Celebration — Series A
- Geoni Capital (https://capitalatlas.ai/funds/geoni-capital) — Series A
- First Samuel Limited — Series A
- Applecross Secretarial Services Pty. Ltd. — Series A
- Binco Securities Pty. Limited — Series A
- Gwb Superannuation Pty Ltd — Series A
- Mal-Fam Nominees Pty. Limited — Series A
- Moore Family Nominee Pty Limited — Series A
- Our Barnyard Pty Ltd — Series A
- Radiata Super Pty Ltd — Series A
- Rothwell Holdings Pte. Ltd. — Series A
- Shiawaseyo Pty Ltd — Series A
- Warana Grange Pty. Ltd. — Series A